RRC ID 45013
Author Zhao W, Zhang Y, Liu D, Zhong L, He Q, Zhao Y.
Title Abnormal expression of CD66a promotes proliferation and inhibits apoptosis of human leukemic B cells in vitro.
Journal Leuk Lymphoma
Abstract The aberrant expression of myeloid antigen CD66 on acute B-lymphoblastic leukemia (B-ALL) cells is a well-documented phenomenon. CD66a is a major subtype of the CD66 family which plays a dual role in different cancers, and the contradictory effect may depend on the isoform ratio of CD66a-4L to CD66a-4S. Although the abnormal expression of CD66a on leukemic B-cells has been reported widely, little is known about the biological function of this aberrant expression. In this study, we showed that inhibition of CD66a in human B-ALL cell lines reduced the cellular proliferative rate and increased the percentage of cellular apoptosis, and the ratio of CD66a-4L to CD66a-4S in leukemic B cells is much higher than that in granulocytes. In addition, alteration of the L:S ratio by silencing and overexpressing the L isoform in B-ALL cell lines confirmed that a high L:S ratio of CD66a in leukemic B cells promotes proliferation and inhibits FasL-induced apoptosis.
Volume 56(1)
Pages 202-10
Published 2015-1-1
DOI 10.3109/10428194.2014.913287
PMID 24716460
MeSH Antigens, CD / genetics* Antigens, CD / metabolism Apoptosis / genetics* Caspases / metabolism Cell Adhesion Molecules / genetics* Cell Adhesion Molecules / metabolism Cell Line, Tumor Cell Membrane / metabolism Cell Proliferation Fas Ligand Protein / genetics Fas Ligand Protein / metabolism Gene Expression* Granulocytes / metabolism Humans Leukemia, B-Cell / genetics* Leukemia, B-Cell / metabolism Protein Isoforms RNA Interference RNA, Small Interfering / genetics
IF 2.969
Times Cited 2
WOS Category HEMATOLOGY ONCOLOGY
Resource
Human and Animal Cells BALL-1